share_log

今海医疗(02225)出席AI微创领域技术发展研讨会 共探AI微创领域新未来

Today, Haichang Medical (02225) attended the AI Minimally Invasive Field Technology Development Seminar to explore the new future of AI Minimally Invasive Field together.

Zhitong Finance ·  Nov 28, 2024 17:52

On November 28, a seminar with the theme of "AI Technology Development in the Minimally Invasive Field" was successfully held in Shanghai. As an important academic conference in the domestic minimally invasive AI field, the Chairman of Jinhai Med Tech (02225), Chen Guobao, attended the conference with the core members of the group.

According to the Wise News Finance APP, a seminar with the theme of 'AI Technology Development in the Minimally Invasive Field' was successfully held in Shanghai on November 28. As an important academic conference in the domestic minimally invasive AI field, the Chairman of Jinhai Med Tech (02225), Chen Guobao, attended the conference with the core members of the group. The conference also brought together senior experts from the fields of endoscopy, minimally invasive procedures, and computer artificial intelligence from all over the country to discuss the latest technological advancements and future trends of AI in the minimally invasive field.

big

This seminar covered several important topics, including a brief overview of endoscopy clinical development in China, the application of Generative AI in tumor diagnosis and minimally invasive surgery, discussions on the application of AI in the medical field, Biodesign and innovative design of smart medical devices, the direction of AI-empowered minimally invasive instruments, and exploration of minimally invasive surgery under AI technology. At the conference, the Director General Manager of Jinhai Med Tech, Liu Lei, introduced the company's product services and business development to industry-leading experts. Participants at the seminar collectively discussed Jinhai Med Tech's latest research achievements and future development in the field of AI in minimally invasive procedures.

With continuous technological development and innovation, AI technology will become an important supporting force in the field of minimally invasive diagnosis and treatment, providing more efficient, precise, and safe medical services for doctors and patients. Wise News Finance understands that Jinhai Med Tech has over 60 patents, more than 20 trademarks, and over 30 projects in research. Among them, Jinhai Med Tech has pioneered an AI intelligent ultra-high-definition endoscope camera system, combining AI with the internet and new technologies for medical minimally invasive technology, greatly enhancing the efficiency of endoscopes, making products smarter, and minimally invasive surgeries more precise. In the rapid development of AI, Jinhai Med Tech is actively promoting technological research and development towards 'Minimally Invasive 5.0'. The company will focus on AI, molecular probes, multispectral, intelligent navigation, AR enhancement, and infrared technologies, actively promoting product intelligence and precision.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment